semaglutide clinical trial in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled Post hoc analysis of SUSTAIN

GLP-1 is shorthand for a class of medications that has reshaped weight care in the last few years

The mass spectrometer was operated in positive ion mode, and the scanning range was set to 300 to 2200 m/z

After 10 days of treatment with Liraglutide, patients had decreased responses in the insula and putamen to food pictures vs the control group treated with insulin glargine

Maintenance treatments, including glutathione injections or IV drips, are needed to sustain the effects as natural skin regeneration and melanin production continue over time

The differences in how these drugs work at a molecular level are clearly reflected in the clinical results